메뉴 건너뛰기




Volumn 378, Issue 9808, 2011, Pages 1980-1981

Statins and safety: Can we finally be reassured?

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN;

EID: 83255193907     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61544-4     Document Type: Note
Times cited : (13)

References (13)
  • 1
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
    • Cholesterol Treatment Trialists' (CTT) Collaborators
    • Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
    • (2005) Lancet , vol.366 , pp. 1267-1278
  • 2
    • 78449281377 scopus 로고    scopus 로고
    • Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials
    • Cholesterol Treatment Trialists' (CTT) Collaboration
    • Cholesterol Treatment Trialists' (CTT) Collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Lancet 376 2010 1670 1681
    • (2010) Lancet , vol.376 , pp. 1670-1681
  • 3
    • 23944487796 scopus 로고    scopus 로고
    • Statins and prostate cancer risk: A case-control study
    • J Shannon, S Tewoderos, M Garzotto et al. Statins and prostate cancer risk: a case-control study Am J Epidemiol 162 2005 318 325
    • (2005) Am J Epidemiol , vol.162 , pp. 318-325
    • Shannon, J.1    Tewoderos, S.2    Garzotto, M.3
  • 4
    • 19444364509 scopus 로고    scopus 로고
    • Statins and the risk of colorectal cancer
    • JN Poynter, SB Gruber, PD Higgins et al. Statins and the risk of colorectal cancer N Engl J Med 352 2005 2184 2192
    • (2005) N Engl J Med , vol.352 , pp. 2184-2192
    • Poynter, J.N.1    Gruber, S.B.2    Higgins, P.D.3
  • 5
    • 0026795925 scopus 로고
    • Report of the conference on low blood cholesterol: Mortality associations
    • D Jacobs, H Blackburn, M Higgins et al. Report of the conference on low blood cholesterol: mortality associations Circulation 86 1992 1046 1060
    • (1992) Circulation , vol.86 , pp. 1046-1060
    • Jacobs, D.1    Blackburn, H.2    Higgins, M.3
  • 6
    • 0026681128 scopus 로고
    • Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial
    • JD Neaton, H Blackburn, D Jacobs et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial Arch Intern Med 152 1992 1490 1500
    • (1992) Arch Intern Med , vol.152 , pp. 1490-1500
    • Neaton, J.D.1    Blackburn, H.2    Jacobs, D.3
  • 7
    • 34447627450 scopus 로고    scopus 로고
    • Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: Insights from large randomized statin trials
    • AA Alsheikh-Ali, PV Maddukuri, H Han, RH Karas Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials J Am Coll Cardiol 50 2007 409 418
    • (2007) J Am Coll Cardiol , vol.50 , pp. 409-418
    • Alsheikh-Ali, A.A.1    Maddukuri, P.V.2    Han, H.3    Karas, R.H.4
  • 8
    • 0025767962 scopus 로고
    • Might treatment of hypercholesterolaemia increase non-cardiac mortality?
    • MF Oliver Might treatment of hypercholesterolaemia increase non-cardiac mortality? Lancet 337 1991 1529 1531
    • (1991) Lancet , vol.337 , pp. 1529-1531
    • Oliver, M.F.1
  • 9
    • 0026527178 scopus 로고
    • Should there be a moratorium on the use of cholesterol lowering drugs?
    • G Davey Smith, J Pekkanen Should there be a moratorium on the use of cholesterol lowering drugs? BMJ 304 1992 431 434
    • (1992) BMJ , vol.304 , pp. 431-434
    • Davey Smith, G.1    Pekkanen, J.2
  • 10
    • 0030024585 scopus 로고    scopus 로고
    • Carcinogenicity of lipid-lowering drugs
    • TB Newman, SB Hulley Carcinogenicity of lipid-lowering drugs JAMA 275 1996 55 60
    • (1996) JAMA , vol.275 , pp. 55-60
    • Newman, T.B.1    Hulley, S.B.2
  • 11
    • 35248901000 scopus 로고    scopus 로고
    • Long-term follow-up of the West of Scotland Coronary Prevention Study
    • for the West of Scotland Coronary Prevention Study Group
    • I Ford, H Murray, CJ Packard, J Shepherd, PW Macfarlane, SM Cobbe for the West of Scotland Coronary Prevention Study Group Long-term follow-up of the West of Scotland Coronary Prevention Study N Engl J Med 357 2007 1477 1486
    • (2007) N Engl J Med , vol.357 , pp. 1477-1486
    • Ford, I.1    Murray, H.2    Packard, C.J.3    Shepherd, J.4    MacFarlane, P.W.5    Cobbe, S.M.6
  • 12
    • 80054741504 scopus 로고    scopus 로고
    • The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK
    • on behalf of the ASCOT Investigators 10.1093/eurheartj/ehr333 published online Aug 28.
    • PS Sever, CL Chang, AK Gupta, A Whitehouse, NR Poulter on behalf of the ASCOT Investigators The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK Eur Heart J 2011 10.1093/eurheartj/ehr333 published online Aug 28.
    • (2011) Eur Heart J
    • Sever, P.S.1    Chang, C.L.2    Gupta, A.K.3    Whitehouse, A.4    Poulter, N.R.5
  • 13
    • 83255193890 scopus 로고    scopus 로고
    • Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: A randomised controlled trial
    • Heart Protection Study Collaborative Group 10.1016/S0140-6736(11)61125-2 published online Nov 23.
    • Heart Protection Study Collaborative Group Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial Lancet 2011 10.1016/S0140-6736(11)61125-2 published online Nov 23.
    • (2011) Lancet


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.